Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Healthcare and industrial adhesives group Scapa posted a first-half loss after it was hurt by reduced volumes, though the blow was partly offset by cost cutting and government support.
Pre-tax losses for the six months through September amounted to £0.5 million, compared to losses of £1.0 million year-on-year.
Revenue fell 24% to £122.0 million, though it improved 23% sequentially from the first quarter to the second.
Scapa said demand in its healthcare division was hurt by a postponement of elective surgeries and reduced footfall across retail channels.
There had been early signs of improvement in the third quarter, albeit cautious given the recent global resurgence of Covid-19 infections.
Demand in the industrial division had recovered to pre-Covid-19 levels at the end of the second quarter, which was expected to positively impact revenues in the second half.
'Whilst uncertainty remains given the recent global resurgence of Covid-19 infections, revenue in both divisions in the second half is expected to exceed the first, with earnings benefitting from additional volumes and cost improvement programmes already implemented,' the company said.
At 9:15am: (LON:SCPA) Scapa Group PLC share price was 0p at 148.4p